Healthleap Raises $38M in Funding

Healthleap, a San Francisco-based clinical AI platform that screens patients for undiagnosed conditions, has raised $38 million in combined seed and Series A funding. The company, which currently operates in more than 50 hospitals, analyzes patient electronic health records to help clinical teams identify and treat conditions like malnutrition, congestive heart failure, and hospital-acquired infections earlier in the care process.

Investors

The funding round included participation from Sequoia Capital, First Round Capital, and Hummingbird Ventures.

Healthleap Use of Funds

Healthleap plans to use the new capital to expand its platform to cover additional medical conditions and to grow its engineering, sales, customer success, and product teams.

About Healthleap

Founded in 2022 by siblings Josiah Meyer and Jemima Meyer, Healthleap provides a clinical AI platform designed to help hospitals identify undiagnosed conditions among inpatients. By continuously analyzing EHR data including notes, labs, and vitals, the software provides actionable risk scores directly into clinical workflows to support faster interventions.

Funding Details

Company Website: https://healthleap.ai

Company: Healthleap
Raised: $38M
Round: Seed, Series A
Funding Date: October 7, 2026
Additional Investors: Sequoia Capital, First Round Capital, Hummingbird Ventures
Company Website: https://healthleap.ai
Software Category: Healthcare AI
Source: https://www.webwire.com/ViewPressRel.asp?aId=361525